Takeda Catches Rising Tide Of Antisense Neuroscience R&D

 
• By John Davis

Huntington's disease is one of several genetically defined neurological diseases that are being targeted in a multibillion-dollar collaboration forged between the US's Wave Life Sciences and Japan's Takeda, that could include co-commercialization by the biotech in the US.

Brain
Enlarged Ventricles and Nerve Atrophy Seen In Huntington's Patients • Source: Shutterstock

More from Deals

More from Business